NORMAL SITUATION

ONE STOP MEDICAL SHOP

Export PDF

Company — Normal situation.

Financial year 2024 · Closed on 19/12/2024

Net result-59,7 k €-471,0 %over 1 year
Gross margin-15,1 k €-546,5 %over 1 year

Identity

Source · BCE/KBO

ONE STOP MEDICAL SHOP is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0783.291.727
Legal form
Private limited company
Latest accounts
19/12/2024

Financials

Source · NBB, 3 filings

Trend over 3 financial years

202420232022
Income statement
Gross margin-15,1 k €3,4 k €102,4 k €
EBITDA-58,7 k €3 k €102 k €
Operating result-58,7 k €-9,2 k €96,8 k €
Net result-59,7 k €-10,5 k €72,4 k €
Balance sheet
Equity–182 k €92,4 k €
Total assets22,7 k €564,8 k €173,1 k €
Cash22,7 k €37 k €18,9 k €
Debts22,7 k €380,2 k €77,6 k €

Board of directors

Source · NBB, accounts to 19/12/2024

1 active · 2 ended

Active mandates

Nestor Erard

Director · since 28 mai 2024 · 0870.806.216

Represented by Kristiaan Erard

Active

Ended mandates

PV Invest Pharma

Director · since 10 mars 2023 · 0893.658.030

Represented by Pieter Vermeersch

Ended
PV Invest Pharma

Director · until 28 mai 2024 · 0893.658.030

Represented by Pieter Vermeersch

Ended

Full financial information

Source · NBB
202420232022
Type of accountMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202310/03/2022
Closing of the financial year19/12/202431/12/202331/12/2022
Length of the financial year12 months12 months10 months
Filing date24/01/202501/07/202429/07/2023
General meeting19/12/202414/06/202430/06/2023
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 3 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model19/12/202419/12/202424/01/2025DutchPDF
Micro model31/12/202314/06/202401/07/2024DutchPDF
Micro model31/12/202230/06/202329/07/2023DutchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 19/12/2024

1 active · 2 ended

Active mandates

Nestor Erard

Director · since 28 mai 2024 · 0870.806.216

Represented by Kristiaan Erard

Active

Ended mandates

PV Invest Pharma

Director · since 10 mars 2023 · 0893.658.030

Represented by Pieter Vermeersch

Ended
PV Invest Pharma

Director · until 28 mai 2024 · 0893.658.030

Represented by Pieter Vermeersch

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution28/01/2025
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
    PDF
  • Mandates08/08/2024
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other14/08/2023
    DIVERSEN
    PDF
  • Mandates26/06/2023
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other14/03/2022
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-59,7 k €↓
  2. 2023
    Annual accounts 2023-10,5 k €↓
  3. 2022
    Annual accounts 202272,4 k €